Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.
Bertheau P, Turpin E, Rickman DS, Espié M, de Reyniès A, Feugeas JP, Plassa LF, Soliman H, Varna M, de Roquancourt A, Lehmann-Che J, Beuzard Y, Marty M, Misset JL, Janin A, de Thé H.
Bertheau P, et al.
PLoS Med. 2007 Mar;4(3):e90. doi: 10.1371/journal.pmed.0040090.
PLoS Med. 2007.
PMID: 17388661
Free PMC article.